Hologic Inc. buy melinda
Start price
02.11.17
/
50%
€34.72
Target price
29.12.17
€40.59
Performance (%)
12.39%
End price
29.12.17
€39.02
Summary
This prediction ended on 29.12.17 with a price of €39.02. The prediction had a final performance of 12.39%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Hologic Inc. | 0.000% | 0.000% | 4.959% | -17.959% |
| iShares Core DAX® | -0.821% | -2.027% | 9.725% | 57.409% |
| iShares Nasdaq 100 | -1.743% | -5.354% | -0.863% | 80.459% |
| iShares Nikkei 225® | 1.215% | 6.383% | 27.786% | 62.930% |
| iShares S&P 500 | -1.167% | -3.462% | 0.098% | 55.836% |
According to melinda what are the pros and cons of Hologic Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Hologic Inc. diskutieren
Globale Tuberkulose Testmarkt.
Hologic ist die Nummer 1 weltweit in der Entwicklung, Herstellung und Vermarktung von Diagnosesystemen und medizinischer Bildgebung auf der Gesundheit von Frauen gewidmet. Der Anwendungsbereich der Gruppe ist wie folgt: - Mammographie (39,3%): Mammographie-Systeme, Detektoren ..
(Vom Mitglied beendet)
Stopped prediction by melinda for Hologic Inc.
Hologic Inc.
Start price
Target price
Perf. (%)
€49.93
07.06.21
07.06.21
€55.00
07.06.22
07.06.22
42.14%
08.06.22
08.06.22
Could be worthwhile Investment >10% per year
Hologic Inc.
Start price
Target price
Perf. (%)
€56.50
20.10.20
20.10.20
€60.00
04.11.21
04.11.21
-11.63%
07.06.21
07.06.21
Could be worthwhile Investment >10% per year
Hologic Inc.
Start price
Target price
Perf. (%)
€36.31
07.02.18
07.02.18
€39.24
30.07.18
30.07.18
7.30%
30.07.18
30.07.18
Could be worthwhile Investment >10% per year